J. H. Beijnen

The Netherlands Cancer Institute — Netherlands

Medicine · Health Sciences

11h-index399citations36works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(8), Colorectal Cancer Treatments and Studies(5), Cancer, Lipids, and Metabolism(5), Lung Cancer Treatments and Mutations(3), Advanced Proteomics Techniques and Applications(3)

Publications36 total

Reversal of resistance to docetaxel and cabazitaxel in prostate cancer cells with ritonavir
European Journal of Cancer·2022· 1 citedOpen Access
829P A proof of concept study of sequential treatment with the HDAC inhibitor vorinostat plus BRAF and MEK inhibitors in BRAFV600 mutated melanoma
Annals of Oncology·2022Open Access
Thermal stability study of crystalline and novel spray-dried amorphous nilotinib hydrochloride
Journal of Pharmaceutical and Biomedical Analysis·2017· 15 citedOpen Access
Relatie tussen farmacokinetiek van ajmaline en ST-elevatie bij de diagnostiek van het Brugada-syndroom
Data Archiving and Networked Services (DANS)·2016Open Access
Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer
Current Clinical Pharmacology·2013· 9 cited
Demethylating medication in myelodysplastic syndrome : Epigenetics as a target for therapy | Demethylerende medicatie bij myelodysplastisch syndroom
2011
Drug pathway–associated gene polymorphisms in patients with advanced non-small cell lung cancer receiving first-line platinum-gemcitabine combination chemotherapy: A prospective multicenter observational study.
Journal of Clinical Oncology·2011
Eribulin dosing in patients with advanced solid tumors and hepatic impairment.
Journal of Clinical Oncology·2011· 4 cited
Determination of Platinum Originating from Carboplatin in Human Urine and Canine Excretion Products by Inductively Coupled Plasma Mass Spectrometry
Journal of Analytical Toxicology·2011· 4 citedOpen Access
574 Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole (KET)
European Journal of Cancer Supplements·2010· 6 cited
Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting
2010· 25 cited
DPYD single nucleotide polymorphisms (SNPs) and haplotypes in patients (pts) with metastatic colorectal cancer and toxicity of capecitabine.
Journal of Clinical Oncology·2010
Use of serum proteins identified by proteomics to predict prognosis in patients with metastatic renal cell cancer (mRCC) and comparison to the currently used MSKCC survival model
Journal of Clinical Oncology·2009
Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting
International Journal of Gynecological Cancer·2009· 105 cited
Evaluation of Human Plasma Protein Binding of Trabectedin (Yondelis™, ET-743)
Current Clinical Pharmacology·2009· 12 cited
Searching for early breast cancer biomarkers by serum protein profiling in Prospect-EPIC
European Journal of Cancer Supplements·2008
P12 SELDI-TOF MS serum protein profiling predicts poor prognosis renal cancer patients
European Journal of Cancer Supplements·2007· 1 cited
Relationship between persistent neurotoxicity and long-term platinum exposure after treatment with cisplatin
Journal of Clinical Oncology·2007
Serum proteomic profiling of advanced gastric cancer and identification of proteomic changes following response to epirubicin, cisplatin and capecitabine chemotherapy as diagnostic and predictive biomarkers
Journal of Clinical Oncology·2007· 3 cited
Effect of oxaliplatin-capecitabine first-line chemotherapy and tumor response on serum proteomic profiles in advanced colorectal cancer and identification of diagnostic biomarkers
Journal of Clinical Oncology·2006· 2 cited
page 1 of 2Next →

Frequent Co-authors

Jan H.M. Schellens(13), Hilde Rosing(6), Alwin D. R. Huitema(5), Judith YMN Engwegen(4), Rolf W. Sparidans(3), J. H. M. Schellens(3), Jan Schellens(3), Helgi H. Helgason(3), J. Schellens(3), Emile E. Voest(3), Annemieke Cats(3), Frédéric Amant(2), Kristel Van Calsteren(2), M Halaška(2), Lieven Lagae(2), Lore Lannoo(2), László Ungár(2), Ignace Vergote(2), Andreas du Bois(2), Amon R. Wafelman(2)